Clinical Trial Update: Post-Ibrutinib Colitis and Intestinal Microbiota

View source ↗

Summary

This clinical trial update from Nantes University Hospital investigates post-ibrutinib colitis and its association with the intestinal microbiota.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colitis

Drugs mentioned

• Ibrutinib (ibrutinib)

Snippet

Sponsor: Nantes University Hospital | Conditions: Gastrointestinal Microbiome | Status: UNKNOWN